Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Genet Med. 2018 Feb 1;20(10):1186–1195. doi: 10.1038/gim.2017.243

Figure 1.

Figure 1.

Attitudes about reporting, by specialty and finding. Findings include a pathogenic RYR1 variant associated with risk for malignant hyperthermia (“ACMG list”), a pathogenic PALB2 variant associated with risk for breast cancer risk (“Has ClinGen summary”), a pathogenic CHEK2 variant associated with risk for cancer (“No ClinGen summary”), a BRCA1 variant of uncertain significance in a patient with a family history of ovarian cancer (“VUS w family history”), and carrier status for three autosomal recessive conditions. P values summarize tests for non-equivalence comparing genetic specialists and non-genetic specialists (“specialty”) and comparing findings (“finding”), and include a test for interaction between specialty and finding (“interaction”).